The Impact of COVID-19 Pandemic on the Pharmaceutical Supply Chain in Freetown: A Phenomenological study
This phenomenological study of 100 pharmacy professionals in Freetown, Sierra Leone, reveals that the COVID-19 pandemic severely disrupted the local pharmaceutical supply chain through increased stock-outs, price fluctuations, and delivery delays caused by border restrictions and lockdowns, highlighting the urgent need for improved government and industry strategies to manage future supply interruptions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a global health crisis strikes, the most immediate concern is often the virus itself, but the machinery that keeps a society functioning is equally fragile. At the heart of this machinery is the pharmaceutical supply chain, a complex network responsible for moving medicines from factories to the shelves of pharmacies and the shelves of hospital wards. This system relies on a steady flow of raw materials, manufacturing, and transportation, all of which can be easily disrupted by border closures, travel bans, or panic. In countries with limited resources, where local production is minimal and reliance on imports is high, these disruptions can be catastrophic, leaving patients without the essential drugs they need to survive. Understanding how these networks break down during a crisis is not just an academic exercise; it is a matter of life and death, revealing where the system is strong and where it is dangerously thin.
In Sierra Leone, a team of researchers set out to understand exactly how the COVID-19 pandemic affected this vital network in Freetown, the nation's capital and most populous district. Between September 2022 and February 2023, they spoke with one hundred pharmacy professionals who had lived through the crisis. These participants worked in a mix of government hospitals, regulatory bodies, and private pharmacies, offering a wide view of the situation. The researchers did not simply count empty shelves; they used a method designed to capture the personal, lived experiences of these workers, asking them to describe what they saw, felt, and managed during the height of the pandemic. The goal was to move beyond statistics and understand the human reality of a supply chain under siege.
The picture that emerged was one of significant strain. Every single participant reported that the time it took to get medicines from the point of order to the point of delivery had changed, and for nearly all of them, the change was negative. Before the pandemic, a typical order might have arrived in a week or a month, depending on the facility. During the crisis, these timelines stretched, creating a bottleneck that left facilities waiting longer for their supplies. This delay was not just an inconvenience; it led to a severe shortage of stock. Ninety-five percent of the professionals interviewed said they ran out of products more often during the pandemic than they did before. For many, these shortages were not minor gaps but critical failures, with nearly three-quarters describing the lack of supplies as very serious and another significant portion calling them extremely serious.
The reasons for these shortages were a tangled web of global and local issues. The researchers found that the lack of active pharmaceutical ingredients—the raw materials needed to make medicines—was a major hurdle for manufacturers. Simultaneously, border restrictions and lockdowns meant that shipping containers were stuck, and trucks could not move freely. This created a backlog where goods were physically present but unable to reach the people who needed them. The situation was compounded by a surge in demand for specific items. As people sought ways to protect themselves, sales of vitamins, immune boosters, hand sanitizers, and face masks skyrocketed. This sudden shift in what people wanted to buy left other essential medicines gathering dust or expiring on shelves, while the popular items vanished almost instantly.
The financial impact on the sector was equally stark. Almost all the professionals reported that the cost of products fluctuated wildly and generally increased, squeezing their profit margins. Eighty-five percent said their profits actually went down during the pandemic, a counterintuitive result given the high demand, because the cost of acquiring goods rose faster than they could sell them, and many products simply could not be sourced at all. Despite these challenges, the study found that the government's response was viewed positively by the vast majority of those surveyed. Ninety-three percent felt the government handled the outbreak well, citing the rapid establishment of emergency centers and effective public awareness campaigns. The government had pre-positioned stocks in various districts and ensured vehicles were available for transport, which helped mitigate some of the worst effects.
However, the study also highlighted that the system remains fragile. The researchers noted that Sierra Leone relies heavily on importing medicines from other countries, making it vulnerable to global disruptions. The participants offered clear recommendations for the future: the country needs to build its own local pharmaceutical manufacturing capabilities to reduce dependence on imports, and the health system needs better training for staff on how to manage supply chains during emergencies. They also called for stronger infrastructure and more consistent coordination between different parts of the health system. The study concludes that while the government did a good job managing the immediate crisis, the pharmaceutical supply chain in Freetown needs fundamental strengthening to survive the next global emergency. By learning from these disruptions, the country can build a system that is not just reactive, but resilient enough to keep medicines flowing when the world stops moving.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.